Omeros Stock Price To Sales

OMER Stock

USD 7.63 0.86 10.13%

Omeros fundamentals help investors to digest information that contributes to Omeros' financial success or failures. It also enables traders to predict the movement of Omeros Stock. The fundamental analysis module provides a way to measure Omeros' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omeros stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	12.73	12.09

As of 12/15/2024, Price To Sales Ratio is likely to drop to 12.09.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Omeros Company Price To Sales Analysis

Omeros' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Omeros Price To Sales

4.93 X

Most of Omeros' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omeros is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Omeros Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Omeros is extremely important. It helps to project a fair market value of Omeros Stock properly, considering its historical fundamentals such as Price To Sales. Since Omeros' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Omeros' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Omeros' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Long Term Investments	Capital Stock
Total Assets		0.06	-0.4	0.9	-0.52	0.6	0.74	0.86	0.91	0.98	0.72	0.63	0.86	0.86	0.81	0.82	0.76	0.49	0.65	0.9	0.87	-0.46	0.86
Total Stockholder Equity	0.06		0.07	0.33	0.68	0.18	0.15	-0.08	-0.27	0.05	0.13	0.14	-0.17	-0.11	0.2	-0.14	-0.2	-0.03	-0.06	0.13	0.11	-0.07	-0.18
Current Deferred Revenue	-0.4	0.07		-0.38	0.27	-0.47	-0.24	-0.41	-0.39	-0.4	-0.15	-0.15	-0.39	-0.52	-0.16	-0.54	-0.67	-0.56	-0.59	-0.29	-0.27	0.17	-0.38
Net Debt	0.9	0.33	-0.38		-0.33	0.56	0.5	0.83	0.76	0.84	0.54	0.43	0.77	0.79	0.9	0.69	0.68	0.45	0.59	0.95	0.93	-0.69	0.81
Retained Earnings	-0.52	0.68	0.27	-0.33		-0.28	-0.21	-0.53	-0.7	-0.48	-0.23	-0.16	-0.6	-0.52	-0.44	-0.5	-0.55	-0.35	-0.39	-0.51	-0.5	0.32	-0.64
Accounts Payable	0.6	0.18	-0.47	0.56	-0.28		0.35	0.31	0.47	0.53	0.14	0.07	0.57	0.7	0.3	0.75	0.63	0.58	0.61	0.49	0.37	-0.1	0.52
Net Receivables	0.74	0.15	-0.24	0.5	-0.21	0.35		0.49	0.58	0.82	0.94	0.94	0.4	0.42	0.42	0.47	0.43	0.32	0.39	0.45	0.41	0.14	0.37
Short Term Investments	0.86	-0.08	-0.41	0.83	-0.53	0.31	0.49		0.82	0.86	0.59	0.51	0.81	0.79	0.79	0.69	0.78	0.53	0.69	0.82	0.86	-0.62	0.85
Total Liab	0.91	-0.27	-0.39	0.76	-0.7	0.47	0.58	0.82		0.87	0.6	0.5	0.87	0.81	0.74	0.78	0.75	0.38	0.55	0.85	0.83	-0.49	0.88
Total Current Assets	0.98	0.05	-0.4	0.84	-0.48	0.53	0.82	0.86	0.87		0.8	0.74	0.81	0.81	0.73	0.79	0.76	0.52	0.67	0.81	0.79	-0.33	0.79
Short Term Debt	0.72	0.13	-0.15	0.54	-0.23	0.14	0.94	0.59	0.6	0.8		0.98	0.4	0.34	0.56	0.36	0.37	0.16	0.25	0.53	0.54	-0.02	0.42
Common Stock	0.63	0.14	-0.15	0.43	-0.16	0.07	0.94	0.51	0.5	0.74	0.98		0.29	0.24	0.45	0.28	0.3	0.18	0.23	0.4	0.42	0.1	0.29
Property Plant Equipment	0.86	-0.17	-0.39	0.77	-0.6	0.57	0.4	0.81	0.87	0.81	0.4	0.29		0.93	0.66	0.89	0.8	0.44	0.62	0.84	0.81	-0.53	0.94
Long Term Debt	0.86	-0.11	-0.52	0.79	-0.52	0.7	0.42	0.79	0.81	0.81	0.34	0.24	0.93		0.56	0.96	0.9	0.65	0.82	0.76	0.71	-0.48	0.88
Net Tangible Assets	0.81	0.2	-0.16	0.9	-0.44	0.3	0.42	0.79	0.74	0.73	0.56	0.45	0.66	0.56		0.44	0.45	0.19	0.31	0.95	0.97	-0.75	0.76
Long Term Debt Total	0.82	-0.14	-0.54	0.69	-0.5	0.75	0.47	0.69	0.78	0.79	0.36	0.28	0.89	0.96	0.44		0.93	0.65	0.82	0.67	0.6	-0.26	0.85
Capital Surpluse	0.76	-0.2	-0.67	0.68	-0.55	0.63	0.43	0.78	0.75	0.76	0.37	0.3	0.8	0.9	0.45	0.93		0.73	0.87	0.62	0.6	-0.32	0.82
Deferred Long Term Liab	0.49	-0.03	-0.56	0.45	-0.35	0.58	0.32	0.53	0.38	0.52	0.16	0.18	0.44	0.65	0.19	0.65	0.73		0.93	0.29	0.27	-0.08	0.45
Short Long Term Debt	0.65	-0.06	-0.59	0.59	-0.39	0.61	0.39	0.69	0.55	0.67	0.25	0.23	0.62	0.82	0.31	0.82	0.87	0.93		0.45	0.42	-0.21	0.63
Net Invested Capital	0.9	0.13	-0.29	0.95	-0.51	0.49	0.45	0.82	0.85	0.81	0.53	0.4	0.84	0.76	0.95	0.67	0.62	0.29	0.45		0.99	-0.73	0.89
Net Working Capital	0.87	0.11	-0.27	0.93	-0.5	0.37	0.41	0.86	0.83	0.79	0.54	0.42	0.81	0.71	0.97	0.6	0.6	0.27	0.42	0.99		-0.77	0.87
Long Term Investments	-0.46	-0.07	0.17	-0.69	0.32	-0.1	0.14	-0.62	-0.49	-0.33	-0.02	0.1	-0.53	-0.48	-0.75	-0.26	-0.32	-0.08	-0.21	-0.73	-0.77		-0.59
Capital Stock	0.86	-0.18	-0.38	0.81	-0.64	0.52	0.37	0.85	0.88	0.79	0.42	0.29	0.94	0.88	0.76	0.85	0.82	0.45	0.63	0.89	0.87	-0.59

Click cells to compare fundamentals

Omeros Price To Sales Historical Pattern

Today, most investors in Omeros Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Omeros' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Omeros price to sales as a starting point in their analysis.

Omeros Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Omeros

Price To Sales Ratio Over Time

Omeros Price To Sales Ratio

Price To Sales Ratio

12.09

At this time, Omeros' Price To Sales Ratio is relatively stable compared to the past year.

Based on the latest financial disclosure, Omeros has a Price To Sales of 4.9338 times. This is 76.94% lower than that of the Pharmaceuticals sector and 94.99% lower than that of the Health Care industry. The price to sales for all United States stocks is 56.8% higher than that of the company.

Omeros Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omeros' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omeros could also be used in its relative valuation, which is a method of valuing Omeros by comparing valuation metrics of similar companies.

Omeros is currently under evaluation in price to sales category among its peers.

Omeros Current Valuation Drivers

We derive many important indicators used in calculating different scores of Omeros from analyzing Omeros' financial statements. These drivers represent accounts that assess Omeros' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Omeros' important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	541.2M	697.8M	817.1M	141.8M	205.2M	289.0M
Enterprise Value	686.8M	730.5M	839.1M	472.8M	559.6M	360.6M

Omeros ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Omeros' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Omeros' managers, analysts, and investors.

Environmental

Governance

Social

Omeros Fundamentals

	Return On Equity	-5.76
	Return On Asset	-0.27
	Current Valuation	528.47 M
	Shares Outstanding	57.95 M
	Shares Owned By Insiders	4.44 %
	Shares Owned By Institutions	43.67 %
	Number Of Shares Shorted	8.92 M
	Price To Earning	0.73 X
	Price To Book	8.44 X
	Price To Sales	4.93 X
	Gross Profit	(71.4 M)
	EBITDA	(163.61 M)
	Net Income	(117.81 M)
	Cash And Equivalents	122.56 M
	Cash Per Share	1.95 X
	Total Debt	361.58 M
	Current Ratio	5.01 X
	Book Value Per Share	(2.66) X
	Cash Flow From Operations	74.73 M
	Short Ratio	6.15 X
	Earnings Per Share	(3.14) X
	Price To Earnings To Growth	(0.17) X
	Target Price	43.0
	Number Of Employees	198
	Beta	1.48
	Market Capitalization	442.16 M
	Total Asset	378.27 M
	Retained Earnings	(753.53 M)
	Working Capital	306.85 M
	Current Asset	37.15 M
	Current Liabilities	16.25 M
	Net Asset	378.27 M

About Omeros Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Omeros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omeros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omeros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Omeros

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Omeros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will appreciate offsetting losses from the drop in the long position's value.

Moving together with Omeros Stock

0.85	ESPR	Esperion Therapeutics	Pair Corr
0.74	BMY	Bristol Myers Squibb	Pair Corr

Moving against Omeros Stock

0.84	AMGN	Amgen Inc	Pair Corr
0.75	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.74	AVDL	Avadel Pharmaceuticals	Pair Corr
0.68	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.66	TTOO	T2 Biosystms	Pair Corr

The ability to find closely correlated positions to Omeros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Omeros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Omeros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Omeros to buy it.

The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Omeros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Omeros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Omeros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Omeros Stock Analysis

When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC